WO2003099999A3 - Generation and selection of protein library in silico - Google Patents
Generation and selection of protein library in silico Download PDFInfo
- Publication number
- WO2003099999A3 WO2003099999A3 PCT/US2003/016037 US0316037W WO03099999A3 WO 2003099999 A3 WO2003099999 A3 WO 2003099999A3 US 0316037 W US0316037 W US 0316037W WO 03099999 A3 WO03099999 A3 WO 03099999A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- library
- lead
- sequence
- protein
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/30—Detection of binding sites or motifs
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
- G16B35/20—Screening of libraries
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/60—In silico combinatorial chemistry
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/50—Mutagenesis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Library & Information Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Computing Systems (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03755415A EP1514216A4 (en) | 2002-05-20 | 2003-05-20 | Generation and selection of protein library in silico |
CN038173603A CN1672160B (en) | 2002-05-20 | 2003-05-20 | Method for constructing antibody library based on precursor antibody structure |
JP2004508241A JP2005526518A (en) | 2002-05-20 | 2003-05-20 | Insilico creation and selection of protein libraries |
CA002485732A CA2485732A1 (en) | 2002-05-20 | 2003-05-20 | Generation and selection of protein library in silico |
AU2003248548A AU2003248548B2 (en) | 2002-05-20 | 2003-05-20 | Generation and selection of protein library in silico |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/153,176 US20030022240A1 (en) | 2001-04-17 | 2002-05-20 | Generation and affinity maturation of antibody library in silico |
US10/153,159 | 2002-05-20 | ||
US10/153,159 US7117096B2 (en) | 2001-04-17 | 2002-05-20 | Structure-based selection and affinity maturation of antibody library |
US10/153,176 | 2002-05-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003099999A2 WO2003099999A2 (en) | 2003-12-04 |
WO2003099999A3 true WO2003099999A3 (en) | 2004-09-16 |
Family
ID=29586304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/016037 WO2003099999A2 (en) | 2002-05-20 | 2003-05-20 | Generation and selection of protein library in silico |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1514216A4 (en) |
JP (1) | JP2005526518A (en) |
CN (1) | CN1672160B (en) |
AU (1) | AU2003248548B2 (en) |
CA (1) | CA2485732A1 (en) |
SG (1) | SG135053A1 (en) |
WO (1) | WO2003099999A2 (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7667004B2 (en) * | 2001-04-17 | 2010-02-23 | Abmaxis, Inc. | Humanized antibodies against vascular endothelial growth factor |
AU2004202566B2 (en) * | 2004-06-11 | 2011-07-21 | Li-Te Chin | Method for Producing Human Antibodies with Properties of Agonist, Antagonist, or Inverse Agonist |
RS20070027A (en) | 2004-07-26 | 2008-11-28 | Biogen Idec Ma Inc., | Anti-cd154 antibodies |
PT3540062T (en) | 2004-11-16 | 2021-07-06 | Humanigen Inc | Immunoglobulin variable region cassette exchange |
EP1869084A2 (en) | 2005-03-04 | 2007-12-26 | Biogen Idec MA Inc. | Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues |
NZ591252A (en) * | 2006-03-17 | 2012-06-29 | Biogen Idec Inc | Methods of designing antibody or antigen binding fragments thereof with substituted non-covarying amino acids |
JP5473603B2 (en) * | 2006-10-02 | 2014-04-16 | シー レーン バイオテクノロジーズ, エルエルシー | Design and construction of diverse synthetic peptide and polypeptide libraries |
CN101647022B (en) * | 2007-01-31 | 2012-07-18 | 麦科罗医药科技(武汉)有限公司 | Methods, systems and means for describing the protein conformations and for evaluating proteins conformations based on folding, overall shape and structural sequence |
CA2742969A1 (en) * | 2008-11-07 | 2010-05-14 | Fabrus Llc | Anti-dll4 antibodies and uses thereof |
MX346002B (en) | 2009-06-17 | 2017-03-01 | Abbvie Biotherapeutics Inc | Anti-vegf antibodies and their uses. |
DK2488867T3 (en) * | 2009-10-14 | 2020-11-09 | Janssen Biotech Inc | PROCEDURES FOR AFFINITY MATURE OF ANTIBODIES |
WO2013171810A1 (en) | 2012-05-14 | 2013-11-21 | パナソニック株式会社 | Method for obtaining heat-resistant antibody-presenting phage |
US20140154255A1 (en) | 2012-11-30 | 2014-06-05 | Abbvie Biotherapeutics Inc. | Anti-vegf antibodies and their uses |
JP6377078B2 (en) * | 2013-01-31 | 2018-08-22 | コデクシス, インコーポレイテッド | Method, system, and software for identifying biomolecules having interacting components |
CN104805507B (en) * | 2014-01-29 | 2019-01-22 | 杭州康万达医药科技有限公司 | phage display library and its application and preparation method |
US10665324B2 (en) | 2014-07-07 | 2020-05-26 | Yeda Research And Development Co. Ltd. | Method of computational protein design |
GB201500464D0 (en) * | 2015-01-12 | 2015-02-25 | Crescendo Biolog Ltd | Method of producing optimised therapeutic molecules |
CN107614762B (en) * | 2015-02-24 | 2022-08-05 | 台湾地区“中央研究院” | Single-chain variant fragment antibody library expressed by phage |
CN104789555A (en) * | 2015-04-29 | 2015-07-22 | 江南大学 | Method of expressing regulatory element based on evolution gene by synthesizing single-chain DNA library |
JP6558754B2 (en) | 2015-08-07 | 2019-08-14 | 富士通株式会社 | Information processing apparatus, index dimension extraction method, and index dimension extraction program |
CN116987187A (en) | 2015-09-23 | 2023-11-03 | 豪夫迈·罗氏有限公司 | Optimized variants of anti-VEGF antibodies |
CN106290908A (en) * | 2016-08-07 | 2017-01-04 | 查文娟 | A kind of for kidney injury detection test kit |
JP6778932B2 (en) * | 2016-09-16 | 2020-11-04 | 国立大学法人大阪大学 | Immune entity clustering software |
CN106905435B (en) * | 2017-03-13 | 2020-04-10 | 武汉海沙百得生物技术有限公司 | Method for preparing binding protein based on protein A mutant |
WO2018195134A1 (en) * | 2017-04-18 | 2018-10-25 | X-Chem, Inc. | Methods for identifying compounds |
WO2019036055A2 (en) * | 2017-08-18 | 2019-02-21 | Ignite Biosciences, Inc. | Methods of selecting binding reagents |
KR102615744B1 (en) * | 2017-11-20 | 2023-12-19 | 난트바이오 인코포레이티드 | mRNA DISPLAY ANTIBODY LIBRARY AND METHODS |
CN108304691B (en) * | 2018-02-09 | 2021-05-18 | 北京矿冶科技集团有限公司 | Fragment-based flotation agent molecule design method |
CN108491692B (en) * | 2018-03-09 | 2023-07-21 | 中国科学院生态环境研究中心 | Method for constructing antibiotic resistance gene database |
CN108763870B (en) * | 2018-05-09 | 2021-08-03 | 浙江工业大学 | Construction method of multi-domain protein Linker |
CN109002690B (en) * | 2018-06-08 | 2021-05-18 | 济南大学 | Method for predicting side chain structure of mutant amino acid by constructing CHARMM ROTAMERS force field |
CN108959846B (en) * | 2018-07-03 | 2021-09-14 | 南昌立德生物技术有限公司 | Affinity free energy decomposition algorithm for computer-aided pilot medicament optimization design |
CN109243526B (en) * | 2018-07-12 | 2021-08-03 | 浙江工业大学 | Protein structure prediction method based on specific fragment crossing |
CN109086568B (en) * | 2018-08-16 | 2022-03-11 | 福建工程学院 | Computer antibody combined mutation evolution system and method and information data processing terminal |
CN109801679B (en) * | 2019-01-15 | 2021-02-02 | 广州柿宝生物科技有限公司 | Mathematical sequence reconstruction method for long-chain molecules |
CN113853656A (en) * | 2019-04-09 | 2021-12-28 | Eth苏黎世公司 | System and method for classifying antibodies |
EP3982369A4 (en) * | 2019-06-07 | 2023-06-14 | Chugai Seiyaku Kabushiki Kaisha | Information processing system, information processing method, program, and method for producing antigen-binding molecule or protein |
CN115349128A (en) * | 2020-02-13 | 2022-11-15 | 齐默尔根公司 | Metagenomic libraries and natural product discovery platform |
CN111370074B (en) * | 2020-02-27 | 2023-07-07 | 北京晶泰科技有限公司 | Method and device for generating molecular sequence and computing equipment |
CN111462815B (en) * | 2020-03-27 | 2023-05-02 | 上海祥耀生物科技有限责任公司 | Construction method and device of antibody library |
CN112102883B (en) * | 2020-08-20 | 2023-12-08 | 深圳华大生命科学研究院 | Base sequence coding method and system in FASTQ file compression |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3415395A (en) * | 1994-08-26 | 1996-03-22 | Eli Lilly And Company | Antibody constructs with cdr switched variable regions |
CA2443862A1 (en) * | 2001-04-17 | 2002-10-24 | Peizhi Luo | Structure-based construction of human antibody library |
-
2003
- 2003-05-20 SG SG200600435-2A patent/SG135053A1/en unknown
- 2003-05-20 CN CN038173603A patent/CN1672160B/en not_active Expired - Fee Related
- 2003-05-20 CA CA002485732A patent/CA2485732A1/en not_active Abandoned
- 2003-05-20 AU AU2003248548A patent/AU2003248548B2/en not_active Ceased
- 2003-05-20 WO PCT/US2003/016037 patent/WO2003099999A2/en active Application Filing
- 2003-05-20 EP EP03755415A patent/EP1514216A4/en not_active Withdrawn
- 2003-05-20 JP JP2004508241A patent/JP2005526518A/en not_active Withdrawn
Non-Patent Citations (2)
Title |
---|
CHOTHIA ET AL: "Structural determinants in the sequences of immunoglobulin variable domain", JOURNAL OF MOLECULAR BIOLOGY, vol. 278, 1998, pages 457 - 479, XP004453679 * |
KNAPPIK ET AL: "Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides", JOURNAL OF MOLECULAR BIOLOGY, vol. 296, 2000, pages 57 - 86, XP004461525 * |
Also Published As
Publication number | Publication date |
---|---|
EP1514216A2 (en) | 2005-03-16 |
WO2003099999A2 (en) | 2003-12-04 |
AU2003248548A1 (en) | 2003-12-12 |
EP1514216A4 (en) | 2010-01-06 |
AU2003248548B2 (en) | 2010-03-11 |
CN1672160B (en) | 2010-06-09 |
CA2485732A1 (en) | 2003-12-04 |
CN1672160A (en) | 2005-09-21 |
JP2005526518A (en) | 2005-09-08 |
SG135053A1 (en) | 2007-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003099999A3 (en) | Generation and selection of protein library in silico | |
HK1072957A1 (en) | In vitro peptide expression libraray | |
JP4972191B2 (en) | Methods and compositions for peptide, protein and peptide mimetic synthesis | |
DE69830497D1 (en) | LIBRARY FOR IN VITRO EXPRESSION OF PEPTIDES OR PROTEINS | |
WO2005003345A3 (en) | Look-through mutagenesis | |
WO2002029032A3 (en) | Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating | |
JP2007127631A (en) | Selective separation method for multiply charged peptide applicable to quantitative proteomics | |
Eckelman et al. | The mechanism of peptide-binding specificity of IAP BIR domains | |
WO2001088162A3 (en) | Methods and vectors for generating antibodies in avian species and uses therefor | |
DE69827810D1 (en) | METHOD FOR THROWING BANKS BY CHIMERAL BINDING PETIDES | |
CA2345287A1 (en) | Tgf-beta superfamily mutant members, including morphogenic proteins | |
JP2004531225A5 (en) | ||
NZ509013A (en) | Novel methods for the identification of ligand and target biomolecules | |
Biemann | Laying the groundwork for proteomics: mass spectrometry from 1958 to 1988 | |
WO2001042277A2 (en) | Complementary peptide ligands generated from the human genome | |
AU8649698A (en) | Cell cycle-regulating proteins | |
Cutfield et al. | The amino‐acid sequences of sculpin islet somatostatin‐28 and peptide YY | |
WO2003073351A3 (en) | Screening process | |
AU2003202689A8 (en) | Methods of screening molecular libraries for active molecules that restore the function of target proteins and peptides that restore the function of mutant p53 | |
EP2354156A3 (en) | Nucleic acids and proteins of insect OR83B odorant receptor genes and uses thereof | |
Spirin | Testing the classical two-tRNA-site model for the ribosomal elongation cycle | |
WO1999063094A3 (en) | Nucleotide and protein sequences of gpr1 and methods based thereon | |
WO2023162983A1 (en) | Method for screening for sequence that regulates display efficiency in polynucleotide presentation method | |
Ishida et al. | Engineering Ribosomal Machinery for Noncanonical Amino Acid Incorporation | |
Lee et al. | Linearizable Macrocyclic Peptide Libraries for Affinity Selection-Mass Spectrometry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2485732 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003248548 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004508241 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003755415 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038173603 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2003755415 Country of ref document: EP |